Curemark Engages Benchworks to Provide Marketing and Product Launch Support Services

Tuesday, September 1st - 2009

CHESTERTOWN, MD—Benchworks has a strong foothold in marketing and promoting brands in the pharmaceutical industry, and their experience in successfully launching go-to-market plans for specialty drugs and compounds made them an ideal candidate for the marketing and product launch needs of Curemark, a biotechnology company that develops and markets innovative products to fulfill needs in neurological medicine. 

Benchworks will provide marketing and product launch support services to Curemark, and will work closely with Unit 7, Curemark's branding agency, as well as Rubinstein Public Relations, to maintain consistent brand messaging and targeted brand placement. 

Curemark will also benefit from Benchworks’ pharmaceutical consulting services and have access to top advisors in pharmaceutical branding, MLR and FDA processes, and compound manufacturing.   

ABOUT CUREMARK

Curemark is a drug research and development company focused on the treatment of neurological and other diseases especially those with dysautonomic components by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr.  Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about their innovative science, visit www.curemark.com.